RSS   Newsletter   Contact   Advertise with us

Sanofi and GSK agree with UK government to supply more than 50 million doses of coronaviris vaccine

Christian Fernsby ▼ | July 29, 2020
Sanofi and GSK have reached an agreement, subject to final contract, with the UK government for the supply more than 60 million doses of a coronavirus vaccine.
Doses   GSK

Topics: Sanofi GSK The vaccine candidate, developed by Sanofi in partnership with GSK, is based on the recombinant protein based technology used by Sanofi to produce an influenza vaccine, and GSK’s established pandemic adjuvant technology.